Prospective study investigating the lesion morphology after Everolimus eluting stent (EES) implantation in patients with ST-segment elevation myocardial infarction (STEMI) and stable angina (SAP)

Trial Profile

Prospective study investigating the lesion morphology after Everolimus eluting stent (EES) implantation in patients with ST-segment elevation myocardial infarction (STEMI) and stable angina (SAP)

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Dec 2015

At a glance

  • Drugs Everolimus (Primary)
  • Indications Angina pectoris; Myocardial infarction
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 31 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top